Journal of Dairy Science
Volume 92, Issue 6 , Pages 2423-2434 , June 2009

Prevention of chronic gastritis by fermented milks made with exopolysaccharide-producing Streptococcus thermophilus strains

  • C. Rodríguez

      Affiliations

    • Centro de Referencia para Lactobacilos (CERELA)-CONICET, Chacabuco 145, San Miguel de Tucumán, 4000 Tucumán, Argentina
  • ,
  • M. Medici

      Affiliations

    • Centro de Referencia para Lactobacilos (CERELA)-CONICET, Chacabuco 145, San Miguel de Tucumán, 4000 Tucumán, Argentina
  • ,
  • A.V. Rodríguez

      Affiliations

    • Centro de Referencia para Lactobacilos (CERELA)-CONICET, Chacabuco 145, San Miguel de Tucumán, 4000 Tucumán, Argentina
  • ,
  • F. Mozzi

      Affiliations

    • Centro de Referencia para Lactobacilos (CERELA)-CONICET, Chacabuco 145, San Miguel de Tucumán, 4000 Tucumán, Argentina
  • ,
  • G. Font de Valdez

      Affiliations

    • Centro de Referencia para Lactobacilos (CERELA)-CONICET, Chacabuco 145, San Miguel de Tucumán, 4000 Tucumán, Argentina
    • Cátedra Microbiología Superior, Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, Ayacucho 491, San Miguel de Tucumán, 4000 Tucumán, Argentina
    • Corresponding Author InformationCorresponding author.

Received 17 September 2008 ,Accepted 30 December 2008.

References 

  1. Aalykke C, Lauritsen K. Epidemiology of NSAID-related gastroduodenal mucosal injury. Best. Pract. Res. Clin. Gastroenterol. 2001;15:705–722
  2. Allen A, Hutton DA, Leonard AJ, Pearson JP, Sellers LA. The role of mucus in the protection of the gastroduodenal mucosa. Scand. J. Gastroenterol. 1986;125(Suppl.):71–78
  3. Ashley SW, Sonnenschein LA, Cheung LY. Focal gastritis mucosal blood flow at the site of aspirin-induced ulceration. Am. J. Surg. 1985;149:53–59
  4. Burns AJ, Rowland IR. Anti-carcinogenicity of probiotics and prebiotics. Curr. Issues Intest. Microbiol. 2000;1:13–24
  5. Canadian Council on Animal Care. In: 2nd ed..  Olfert ED,  Cross BM,  Mc William AA editor. Guide to the Care and Use of Experimental Animals. Vol. 1:Ontario, Canada: CCAC, Ottawa; 1998;
  6. Collado MC, Gueimonde M, Hernández M, Sanz Y, Salminen S. Adhesion of selected Bifidobacterium strains to human intestinal mucus and the role of adhesion in enteropathogen exclusion. J. Food Prot. 2005;68:2672–2678
  7. De Vuyst L, Degeest B. Heteropolysaccharides from lactic acid bacteria. FEMS Microbiol. Rev. 1999;23:153–177
  8. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. Am. J. Surg. Pathol. 1996;20:1161–1181
  9. Drago L, Gismondo MR, Lombardi A, de Haen C, Gozzini L. Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol. Lett. 1997;153:455–463
  10. FAO/WHO. 2001. Report on joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. ftp://ftp.fao.org/docrep/fao/meeting/009/y6398e.pdf
  11. Fries JF, Williams CA, Bloch DA. The relative toxicity of nonsteroidal anti-inflammatory drugs. Arthritis Rheum. 1991;34:1353–1360
  12. Gomes AS, Lima LM, Santos CL, Cunha FQ, Ribeiro RA, Souza MH. LPS from Escherichia coli protects against indomethacin-induced gastropathy in rats role of ATP-sensitive potassium channels. Eur. J. Pharmacol. 2006;547:136–142
  13. Ippoliti AF, Maxwel V, Isemberg JI. The effect of various forms of milk on gastric-acid secretion. Ann. Intern. Med. 1976;84:286–289
  14. Johnson-Henry KC, Mitchell DJ, Avitzur Y, Galindo-Mata E, Jones NL, Sherman PM. Probiotics reduce bacterial colonization and gastric inflammation in H. pylori-infected mice. Dig. Dis. Sci. 2004;49:1095–1102
  15. Kalliomäki M, Salminen S, Isolauri E. Positive interactions with the microbiota: Probiotics. Adv. Exp. Med. Biol. 2008;635:57–66
  16. Kidd P. Th1/Th2 balance: The hyphotesis, its limitations, and implications for health and disease. Altern. Med. Rev. 2003;8:223–246
  17. Kitazawa H, Toba T, Itoh T, Kumano N, Adachi S, Yamaguchi T. Antitumoral activity of slime-forming encapsulated Lactococcus lactis subsp. cremoris isolated from Scandinavian ropy sour milk, “viili.”. Anim. Sci. Technol. 1991;62:277–283
  18. Koo MWL. The effects of milk and calcium on ethanol-induced gastric mucosal damage. Pharmacol. Res. 1994;29:217–224
  19. Lam EKY, Tai EKK, Koo MWL, Wong HPS, Wu WKK, Yu L, et al. Enhancement of gastric mucosal integrity by Lactobacillus rhamnosus GG. Life Sci. 2007;80:2128–2136
  20. Lamarque D. Pathogenesis of gastroduodenal lesions induced by non-steroidal anti-inflammatory drugs. Gastroenterol. Clin. Biol. 2004;3:18–26
  21. Looijesteijn PJ, van Casteren WHM, Tuinier R, Doeswijk-Voragen CHL, Hugenholtz J. Influence of different substrate limitations on the yield, composition and molecular mass of exopolysaccharides produced by Lactococcus lactis subsp. cremoris in continuous cultures. J. Appl. Microbiol. 2000;89:116–122
  22. Matsumoto H, Shimokawa Y, Ushida Y, Toida T, Hayasawa H. New biological function of bovine α-lactalbumin: Protective effect against ethanol- and stress-induced gastric mucosal injury in rats. Biosci. Biotechnol. Biochem. 2001;65:1104–1111
  23. Mozzi F, Vaningelgem F, Hébert EM, Van der Meulen R, Foulquié Moreno MR, Font de Valdez G, et al. Diversity of heteropolysaccharide-producing lactic acid bacterium strains and their biopolymers. Appl. Environ. Microbiol. 2006;72:4431–4435
  24. Nagaoka M, Hashimoto S, Watanabe T, Yokokura T, Moro Y. Anti-ulcer effects of lactic acid bacteria and their cell wall polysaccharides. Biol. Pharm. Bull. 1994;17:1012–1017
  25. Nakajima H, Suzuki H, Kaizu H, Hirota T. Cholesterol lowering activity of ropy fermented milk. J. Food Sci. 1992;57:1327–1329
  26. Perdigón G, Maldonado-Galdeano C, de Moreno de LeBlanc A, Vinderola CG, Medici M, Bibas Bonet ME. Immunomodulation of mucosal immune response by probiotics. Curr. Trends Immunol. 2004;6:69–85
  27. Petry S, Furlan S, Waghorne E, Saulnier L, Cerning J, Maguin E. Comparison of thickening properties of four Lactobacillus delbrueckii subsp. bulgaricus strains and physicochemical characterization of their exopolysaccharides. FEMS Microbiol. Lett. 2003;221:285–291
  28. Peyron S, Mouécoucou J, Frémont S, Sánchez C, Gontard N. Effects of heat treatment and pectin addition on β-lactoglobulin allergenicity. J. Agric. Food Chem. 2006;54:5643–5650
  29. Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: Effects of probiotic supplementationon the incidence of C. difficile diarrhea. Int. Microbiol. 2004;7:59–62
  30. Racedo S, Villena J, Medina M, Agüero G, Rodríguez V, Alvarez S. Lactobacillus casei administration reduces lung injuries in a Streptococcus neumoniae infection in mice. Microbes Infect. 2006;8:2359–2366
  31. Roberts IS. The biochemistry and genetics of capsular polysaccharides production in bacteria. Annu. Rev. Microbiol. 1996;50:285–315
  32. Ruas-Madiedo P, De los Reyes-Gavilán CG. Invited review: Methods for the screening, isolation and characterization of exopolysaccharides produced by lactic acid bacteria. J. Dairy Sci. 2005;88:843–856
  33. Ruas-Madiedo P, Hugenholtz J, Zoon P. An overview of the functionality of exopolysaccharides produced by lactic acid bacteria. Int. Dairy J. 2002;12:163–171
  34. Saint-Marie G. A paraffin embedding technique for studies employing immunofluorescence. J. Histochem. Cytochem. 1962;10:250–256
  35. Sanders ME. Overview on functional foods: Emphasis on probiotic bacteria. Int. Dairy J. 1998;8:341–347
  36. Şengül M, Aslím B, Uςar G, Yücel N, Isik S, Bozkurt H, et al. Effects of exopolysaccharide-producing probiotic strains on experimental colitis in rats. Dis. Colon Rectum. 2005;49:250–258
  37. Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, et al. In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota. Appl. Environ. Microbiol. 2004;70:518–526
  38. Stanton C, Ross RP, Fitzgerald GF, Van Sinderen D. Fermented functional foods based on probiotics and their biogenic metabolites. Curr. Opin. Microbiol. 2005;16:198–203
  39. Tolstoguzov VB. Thermodynamic aspects of biopolymers functionality in biological systems, foods, and beverages. Crit. Rev. Biotechnol. 2002;22:89–174
  40. Uchida M, Kurakazu K. Yogurt containing Lactobacillus gasseri OLL2716 exerts gastroprotective action against acute gastric lesions and antral ulcer in rats. J. Pharmacol. Sci. 2004;96:84–90
  41. Vaningelgem F, Zamfir M, Mozzi F, Adriany T, Vancanneyt M, Swings J, et al. Biodiversity of exopolysaccharides produced by Streptococcus thermophilus strains is reflected in their production and their molecular and functional characteristics. Appl. Environ. Microbiol. 2004;70:900–912
  42. Vinderola CG, Duarte J, Thangavel D, Perdigón G, Farnworth E, Matar C. Immunomodulating capacity of kefir. J. Dairy Res. 2005;72:195–202
  43. Vinderola CG, Medici M, Perdigón G. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J. Appl. Microbiol. 2004;96:230–243
  44. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology. 1997;112:1000–1016
  45. Wallace JL, McKnight GW, Bell CJ. Adaptation of rat gastric mucosa to aspirin requires mucosal contact. Am. J. Physiol. 1995;268:G134–G138
  46. Weinbreck F, de Vries R, Schrooyen P, de Kruif CG. Complex coacervation of whey proteins gum arabic. Biomacromolecules. 2003;4:293–303
  47. Yamada H. Structure and pharmacological activity of peptic polysaccharides from the roots of Bupleurum falcatum L. Nippon Yakurigaku Zasshi. 1995;106:229–237
  48. Yamamoto T, Kita M, Ohno T, Iwakura Y, Sekikawa K, Imanishi J. Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol. Immunol. 2004;48:647–654

PII: S0022-0302(09)70557-0

doi: 10.3168/jds.2008-1724

Journal of Dairy Science
Volume 92, Issue 6 , Pages 2423-2434 , June 2009